Disorder outline isolated RBD is a dubious disease in the field of the nervous system, with clinical performance being complex and often involving multi-system congestion. Early identification and standardised clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
A platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment. Treatment and management of isolated RBD require individualized development of treatment regimens, typically including drug therapy, rehabilitation intervention, and regular follow-up to multiple-dimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many formerly difficult-to-treat neurological disorders have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions and timely adjusted according to changing conditions. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of isolated RBD. The platform serves a team of domestic and foreign experts in the field of neural systems aligned with the China International Medical Service System, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.